Sell Wockhardt, target Rs 382: Dr CK Narayan
Sell Wockhardt Ltd. at a price target of Rs 382.0 and a stoploss at Rs 399 from entry point.

Wockhardt Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 2034.35 Crore to Sales Value (82.11 % of Total Sales), Other Goods which contributed Rs 358.49 Crore to Sales Value (14.47 % of Total Sales), Sale of services which contributed Rs 62.24 Crore to Sales Value (2.51 % of Total Sales) and Licence Fees which contributed Rs 22.21 Crore to Sales Value (0.89 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-03-2019, the company has reported a Consolidated sales of Rs 979.13 Crore, down -6.38 % from last quarter Sales of Rs 1045.86 Crore and down -3.84 % from last year same quarter Sales of Rs 1018.26 Crore Company has reported net profit after tax of Rs -13.90 Crore in latest quarter. The company’s top management includes Dr.Habil Khorakiwala, Dr.Huzaifa Khorakiwala, Dr.Murtaza Khorakiwala, Mr.Aman Mehta, Mr.Baldev Raj Arora, Mr.D S Brar, Mr.Sanjaya Baru, Mr.Vinesh Kumar Jairath, Mrs.Tasneem Mehta, Ms.Zahabiya Khorakiwala. Company has Haribhakti & Co. LLP as its auditoRs As on 31-03-2019, the company has a total of 110,686,203 shares outstanding.
Download ET Markets APP